VAERS Explorer
Back to explore

Report #2856710

Received Sep 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
ME
Recovered
Unknown
Vaccinated
Aug 28, 2025
Onset
Aug 28, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
DTAPIPVHIBDTAP + IPV + HIB (PENTACEL)SANOFI PASTEUR1UK216ABOT / LL

Symptoms (2)

No adverse eventProduct preparation issue

Symptom narrative

report an incident involving pentacel wherein a nurse did not reconstitute the powdered HIB component with the liquid DTaP-IPV component with no reported adverse event; Initial information received on 29-Aug-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age male patient to whom administered Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine [Pentacel (Vero)] where a nurse did not reconstitute the powdered hib component with the liquid dtap-ipv component with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE for Immunisation. On 28-Aug-2025, the patient received a 0.5 ml (dose 1) dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine Suspension for injection (strength: unknown, expiry date: 31-Jul-2027 and lot UK216AB) via intramuscular route in the left vastus lateralis. as immunization, where a nurse did not reconstitute the powdered hib component with the liquid dtap-ipv component with no reported adverse event (single component of a two-component product administered) (latency: same day). Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Other medications

PNEUMOCOCCAL VACCINE